DR Horton Inc banner
D

DR Horton Inc
XMUN:HO2

Watchlist Manager
DR Horton Inc
XMUN:HO2
Watchlist
Price: 133.15 EUR 4.02% Market Closed
Market Cap: €27.9B

Wall St Price Targets

HO2 Price Targets Summary
DR Horton Inc

Wall Street analysts forecast HO2 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HO2 is 146.76 EUR with a low forecast of 106.78 EUR and a high forecast of 185.92 EUR.

Lowest Forecast
Price Target
106.78 EUR
20% Downside
Average Forecast
Price Target
146.76 EUR
10% Upside
Highest Forecast
Price Target
185.92 EUR
40% Upside
DR Horton Inc Competitors:
Price Targets
MHO
M/I Homes Inc
15% Upside
HGV
Hilton Grand Vacations Inc
17% Upside
IVA
Inventiva SA
275% Upside
3415
Tokyo Base Co Ltd
43% Upside
ESNT
Essent Group Ltd
12% Upside
HOV
Hovnanian Enterprises Inc
-37% Downside

Revenue
Forecast

17% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
17% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 4%.

Gross Profit
Forecast

19% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
7%
Average Beat
19% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
7%
Average Beat

Over the last 13 years, the compound annual growth rate for Gross Profit has been 19%. The projected CAGR for the next 3 years is 5%.

Operating Income
Forecast

25% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
25% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 3 years is 4%.

Pre-Tax Income
Forecast

26% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
26% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 26%. The projected CAGR for the next 3 years is 2%.

Net Income
Forecast

11% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
11% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 2%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is HO2's stock price target?
Price Target
146.76 EUR

According to Wall Street analysts, the average 1-year price target for HO2 is 146.76 EUR with a low forecast of 106.78 EUR and a high forecast of 185.92 EUR.

What is the Revenue forecast for DR Horton Inc?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 4%.

What is the Gross Profit forecast for DR Horton Inc?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 19%. The projected CAGR for the next 3 years is 5%.

What is the Operating Income forecast for DR Horton Inc?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 3 years is 4%.

What is the Pre-Tax Income forecast for DR Horton Inc?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 26%. The projected CAGR for the next 3 years is 2%.

What is the Net Income forecast for DR Horton Inc?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 2%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett